Toxicity of oxidized phospholipids in cultured macrophages

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Stemmer, Ute ^a   Dunai, Zsuzsanna A ^a,d   Koller, Daniel ^a   Pürstinger, Gabriel ^a   Zenzmaier, Elfriede ^a   Deigner, Hans P ^b,f   Aflaki, Elma ^c,e   Kratky, Dagmar ^c   Hermetter, Albin ^a  

^a GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^b FURTWANGEN UNIVERSITY   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^e NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^f FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

Author keywords

Acid sphingomyelinase; Apoptosis; Apoptotic blebs; Atherosclerosis; Ceramide; Macrophages

Indexed keywords

1 O HEXADECYL 2 (5 OXOVALEROYL)GLYCERO 3 PHOSPHOCHOLINE; 1 O HEXADECYL 2 GLUTAROYLGLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 (5 OXOVALEROYL)GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 GLUTAROYLGLYCERO 3 PHOSPHOCHOLINE; ALDEHYDE; ALKYL ETHER; CERAMIDE; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID DERIVATIVE; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BONE MARROW; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LIPID OXIDATION; MACROPHAGE; MICROPARTICLE ENZYME IMMUNOASSAY; PROTEIN STRUCTURE;

ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; CELL SURVIVAL; CELLS, CULTURED; CERAMIDES; LIPOPROTEINS, LDL; MACROPHAGES; MICE; OXIDATION-REDUCTION; PHOSPHOLIPIDS; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 84865830234     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-110     Document Type: Article

References (46)

1. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA, J Biol Chem 1997 272 13597 13607 10.1074/jbc.272.21.13597 9153208
2. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Kolodgie FD, Narula J, Burke AP, Haider N, Farb A, Hui-Liang Y, Smialek J, Virmani R, Am J Pathol 2000 157 1259 1268 10.1016/S0002-9440(10)64641-X 11021830
3. Acid sphingomyelinase in macrophage apoptosis. Steinbrecher UP, Gomez-Munoz A, Duronio V, Curr Opin Lipidol 2004 15 531 537 10.1097/00041433- 200410000-00006 15361788
4. Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis. Deigner HP, Claus R, Bonaterra GA, Gehrke C, Bibak N, Blaess M, Cantz M, Metz J, Kinscherf R, FASEB J 2001 15 807 814 10.1096/fj.15.3.807 11259399
5. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Seimon TA, Nadolski MJ, Liao X, Magallon J, Nguyen M, Feric NT, Koschinsky ML, Harkewicz R, Witztum JL, Tsimikas S, Golenbock D, Moore KJ, Tabas I, Cell Metab 2010 12 467 482 10.1016/j.cmet.2010.09.010 21035758
6. Modified low density lipoprotein delivers substrate for ceramide formation and stimulates the sphingomyelin-ceramide pathway in human macrophages. Kinscherf R, Claus R, Deigner HP, Nauen O, Gehrke C, Hermetter A, Russwurm S, Daniel V, Hack V, Metz J, FEBS Lett 1997 405 55 59 10.1016/S0014-5793(97)00157-9 9094423
7. Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells. Loidl A, Sevcsik E, Riesenhuber G, Deigner HP, Hermetter A, J Biol Chem 2003 278 32921 32928 10.1074/jbc.M306088200 12816958
8. Lipid second messengers derived from glycerolipids and sphingolipids, and their role in smooth muscle function. Ohanian J, Liu G, Ohanian V, Heagerty AM, Acta Physiol Scand 1998 164 533 548 9887976
9. Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities. Subbanagounder G, Watson AD, Berliner JA, Free Radic Biol Med 2000 28 1751 1761 10.1016/S0891-5849(00)00233-1 10946217
10. The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells. Fruhwirth GO, Moumtzi A, Loidl A, Ingolic E, Hermetter A, Biochim Biophys Acta 2006 1761 1060 1069 10.1016/j.bbalip.2006.06.001 16904371
11. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. Marathe GK, Davies SS, Harrison KA, Silva AR, Murphy RC, Castro-Faria-Neto H, Prescott SM, Zimmerman GA, McIntyre TM, J Biol Chem 1999 274 28395 28404 10.1074/jbc.274.40. 28395 10497200
12. Oxidized phospholipids: emerging lipid mediators in pathophysiology. Deigner HP, Hermetter A, Curr Opin Lipidol 2008 19 289 294 10.1097/MOL. 0b013e3282fe1d0e 18460921
13. Oxidized phospholipids: from molecular properties to disease. Fruhwirth GO, Loidl A, Hermetter A, Biochim Biophys Acta 2007 1772 718 736 10.1016/j.bbadis.2007.04.009 17570293
14. Uptake and protein targeting of fluorescent oxidized phospholipids in cultured RWA 264.7 macrophages. Stemmer U, Ramprecht C, Zenzmaier E, Stojčić B, Rechberger G, Kollroser M, Hermetter A, Biochim Biophys Acta 2012 1821 706 18 10.1016/j.bbalip.2012.01.014 22333180
15. Protein modification by aldehydophospholipids and its functional consequences. Stemmer U and Hermetter A, Biochim.Biophys.Acta 2012 1818 2436 2445 10.1016/j.bbamem.2012.03.006 22450235
16. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation. Friedman P, Horkko S, Steinberg D, Witztum JL, Dennis EA, J Biol Chem 2002 277 7010 7020 10.1074/jbc.M108860200 11744722
17. Import and fate of fluorescent analogs of oxidized phospholipids in vascular smooth muscle cells. Moumtzi A, Trenker M, Flicker K, Zenzmaier E, Saf R, Hermetter A, J Lipid Res 2007 48 565 582 17135656
18. 1-O-Trityl-Sn-Glycero-3-Phosphocholine-A New Intermediate for the Facile Preparation of Mixed-Acid 1,2-Diacylglycerophosphocholines. Hermetter A, Stutz H, Franzmair R, Paltauf F, Chemistry and Physics of Lipids 1989 50 57 62 10.1016/0009-3084(89)90026-1
19. Single bilayer liposomes prepared without sonication. Batzri S, Korn ED, Biochim Biophys Acta 1973 298 1015 1019 10.1016/0005-2736(73)90408-2 4738145
20. Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Huber J, Vales A, Mitulovic G, Blumer M, Schmid R, Witztum JL, Binder BR, Leitinger N, Arterioscler Thromb Vasc Biol 2002 22 101 107 10.1161/hq0102.101525 11788468
21. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Bradford MM, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051
22. Peptide and protein molecular weight determination by electrophoresis using a high-molarity tris buffer system without urea. Fling SP, Gregerson DS, Anal Biochem 1986 155 83 88 10.1016/0003-2697(86)90228-9 3454661
23. Modified spray for the detection of phospholipids on thin-layer chromatograms. Vaskovsky VE, Kostetsky EY, J Lipid Res 1968 9 396 5646190
24. High-precision fluorescence assay for sphingomyelinase activity of isolated enzymes and cell lysates. Loidl A, Claus R, Deigner HP, Hermetter A, J Lipid Res 2002 43 815 823 11971953
25. Atherosclerosis. the road ahead. Glass CK, Witztum JL, Cell 2001 104 503 516 10.1016/S0092-8674(01)00238-0 11239408
26. The alk-i-enyl ether and alkyl ether lipids of bovine heart muscle. Schmid HH, Takahashi T, Biochim Biophys Acta 1968 164 141 147 10.1016/0005-2760(68)90140-9 5721017
27. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. Aupeix K, Hugel B, Martin T, Bischoff P, Lill H, Pasquali JL, Freyssinet JM, J Clin Invest 1997 99 1546 1554 10.1172/JCI119317 9119998
28. Inhibition of caspases inhibits the release of apoptotic bodies: Bcl-2 inhibits the initiation of formation of apoptotic bodies in chemotherapeutic agent-induced apoptosis. Zhang J, Reedy MC, Hannun YA, Obeid LM, J Cell Biol 1999 145 99 108 10.1083/jcb.145.1.99 10189371
29. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Tabas I, Williams KJ, Boren J, Circulation 2007 116 1832 1844 10.1161/CIRCULATIONAHA.106.676890 17938300
30. Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol. Tabas I, Cell Death Differ 2004 11 Suppl 1 12 S16 15143347
31. Oxidized low-density lipoprotein-induced apoptosis. Salvayre R, Auge N, Benoist H, Negre-Salvayre A, Biochim Biophys Acta 2002 1585 213 221 10.1016/S1388-1981(02)00343-8 12531556
32. The release of microparticles by apoptotic cells and their effects on macrophages. Distler JH, Huber LC, Hueber AJ, Reich CF, Gay S, Distler O, Pisetsky DS, Apoptosis 2005 10 731 741 10.1007/s10495-005-2941-5 16133865
33. Plasma membrane fluidity affects transient immobilization of oxidized phospholipids in endocytotic sites for subsequent uptake. Rhode S, Grurl R, Brameshuber M, Hermetter A, Schutz GJ, J Biol Chem 2009 284 2258 2265 19043088
34. Chemistry and biochemistry of 4- hydroxynonenal, malonaldehyde and related aldehydes. Esterbauer H, Schaur RJ, Zollner H, Free Rad Biol Med 1991 11 81 128 10.1016/0891-5849(91)90192-6 1937131
35. Protein modification by oxidized phospholipids and hydrolytically released lipid electrophiles: Investigating cellular responses. Ullery JC, Marnett LJ, Biochim Biophys Acta 2012 1818 2424 35 10.1016/j.bbamem.2012.04.014 22562025
36. Pathological aspects of lipid peroxidation. Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Cohen G, Feher J, Grune T, Lengyel G, Mann GE, Pamplona R, Poli G, Portero-Otin M, Riahi Y, Salvayre R, Sasson S, Serrano J, Shamni O, Siems W, Siow RC, Wiswedel I, Zarkovic K, Zarkovic N, Free Radic Res 2010 44 1125 71 10.3109/10715762.2010.498478 20836660
37. 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Zarkovic N, Mol Aspects Med 2003 24 281 91 10.1016/S0098-2997(03)00023-2 12893006
38. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. Heery JM, Kozak M, Stafforini DM, Jones DA, Zimmerman GA, McIntyre TM, Prescott SM, J Clin Invest 1995 96 2322 2330 10.1172/JCI118288 7593619
39. Bioactive phospholipid oxidation products. Marathe GK, Harrison KA, Murphy RC, Prescott SM, Zimmerman GA, McIntyre TM, Free Radic Biol Med 2000 28 1762 1770 10.1016/S0891-5849(00)00234-3 10946218
40. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids. Tokumura A, Toujima M, Yoshioka Y, Fukuzawa K, Lipids 1996 31 1251 1258 10.1007/BF02587909 8972457
41. Dipolar solvent relaxation on a nanosecond time scale in ether phospholipid membranes as determined by multifrequency phase and modulation fluorometry. Sommer A, Paltauf F, Hermetter A, Biochemistry 1990 29 11134 11140 10.1021/bi00502a017 2271701
42. Packing of Ether and Ester Phospholipids in Monolayers-Evidence for Hydrogen-Bonded Water at the Sn-1 Acyl Group of Phosphatidylcholines. Smaby JM, Hermetter A, Schmid PC, Paltauf F, Brockman HL, Biochemistry 1983 22 5808 5813 10.1021/bi00294a019
43. The role of membrane lipids in the induction of macrophage apoptosis by microparticles. Huber LC, Jungel A, Distler JH, Moritz F, Gay RE, Michel BA, Pisetsky DS, Gay S, Distler O, Apoptosis 2007 12 363 374 10.1007/s10495-006- 0622-7 17191114
44. Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating beta1 integrin. Shih PT, Elices MJ, Fang ZT, Ugarova TP, Strahl D, Territo MC, Frank JS, Kovach NL, Cabanas C, Berliner JA, Vora DK, J Clin Invest 1999 103 613 625 10.1172/JCI5710 10074478
45. Chronic alcohol exposure increases circulating bioactive oxidized phospholipids. Yang L, Latchoumycandane C, McMullen MR, Pratt BT, Zhang R, Papouchado BG, Nagy LE, Feldstein AE, McIntyre TM, J Biol Chem 2010 285 22211 22220 10.1074/jbc.M110.119982 20460374
46. Lipid microdomains in dimyristoylphosphatidylcholine-ceramide liposomes. Holopainen JM, Lehtonen JY, Kinnunen PK, Chem Phys Lipids 1997 88 1 13 10.1016/S0009-3084(97)00040-6 9297850